Compare MRCY & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRCY | BCPC |
|---|---|---|
| Founded | 1981 | 1967 |
| Country | United States | United States |
| Employees | N/A | 1355 |
| Industry | | Major Chemicals |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 5.5B |
| IPO Year | 1998 | N/A |
| Metric | MRCY | BCPC |
|---|---|---|
| Price | $103.45 | $168.15 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 2 |
| Target Price | $76.43 | ★ $176.00 |
| AVG Volume (30 Days) | ★ 714.8K | 163.8K |
| Earning Date | 02-03-2026 | 02-20-2026 |
| Dividend Yield | N/A | ★ 0.57% |
| EPS Growth | N/A | ★ 22.48 |
| EPS | N/A | ★ 4.57 |
| Revenue | $932,798,000.00 | ★ $1,013,548,000.00 |
| Revenue This Year | $6.47 | $10.41 |
| Revenue Next Year | $8.65 | $6.36 |
| P/E Ratio | ★ N/A | $36.93 |
| Revenue Growth | ★ 8.63 | 7.55 |
| 52 Week Low | $39.42 | $139.17 |
| 52 Week High | $103.84 | $177.40 |
| Indicator | MRCY | BCPC |
|---|---|---|
| Relative Strength Index (RSI) | 85.05 | 71.50 |
| Support Level | $93.97 | $157.85 |
| Resistance Level | $99.38 | $162.50 |
| Average True Range (ATR) | 3.71 | 3.32 |
| MACD | 2.46 | 1.04 |
| Stochastic Oscillator | 99.15 | 96.36 |
Mercury Systems Inc is a commercial technology company serving the aerospace and defense industry. The company envisions, creates, and delivers secure open architecture solutions powering a broad range of mission-critical applications in challenging and demanding environments. Its Mercury Processing Platform spans the full breadth of signal processing from radio frequency front end to the human-machine interface to convert meaningful data, gathered in remote and hostile environments, into critical decisions. The company manufactures components, products, modules, and subsystems and sells to defense prime contractors, the U.S. government, original equipment manufacturers, and commercial aerospace companies. Geographically, it derives maximum revenue from the United States.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.